Lainie Goldstein Buys Shares of Phreesia, Inc.

Lainie Goldstein, an insider at Phreesia, Inc. (NYSE:PHR), purchased 19,290 shares of the company on June 24, 2026. The shares were bought at an average price of $9.59, amounting to a total transaction value of approximately $184,991.10. This move was not part of a pre-planned trading program.

Insider Buying and Selling at Phreesia, Inc.

In addition to Lainie Goldstein's purchase, other insiders were active around the same time. Notably, Mark Douglas Smith, Ramin Sayar, Lisa Egbuonu-Davis, and Gillian Munson each bought 19,290 shares at the same price of $9.59 on June 24, 2026. Lisa Egbuonu-Davis also sold 2,546 shares at $9.53 on June 25, 2026, as part of a planned transaction.

Other Institutional Activity in Phreesia, Inc.

Institutional investors have also shown interest in Phreesia, Inc. Pale Fire Capital SE opened a new position with 8,649,329 shares valued at about $72.5 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC also initiated new stakes, each acquiring over 2.4 million shares. BlackRock, Inc. added 284,445 shares, bringing its total to 5,920,469 shares worth approximately $49.6 million. AQR Capital Management LLC significantly increased its position by 1,415,465 shares, now holding 1,852,559 shares valued at $15.5 million.

Phreesia, Inc. Stock Down 17.1%

Shares of Phreesia, Inc. traded near $9.13 on Saturday. The company, which operates in the healthcare sector offering SaaS-based software solutions, has a market capitalization of roughly $622.4 million. It carries a P/E ratio of 62.94 and a forward P/E of 6.27, with a beta of 0.884. The stock's 52-week range is between $7.77 and $32.76, with a 50-day moving average of $9.38 and a 200-day moving average of $15.21. Phreesia, Inc. maintains a current ratio of 1.76 and a quick ratio of 1.43, alongside a debt-to-equity ratio of 25.78.

Analysts Set New Price Targets

Analysts have recently updated their ratings and targets for Phreesia, Inc. On May 29, 2026, Truist Securities maintained a hold rating with a $12.00 price target. Citigroup also maintained its hold rating at the same target price on May 28, 2026. Meanwhile, Canaccord Genuity and DA Davidson reiterated buy ratings with targets of $16.00 and $14.00, respectively, on May 28. Wells Fargo downgraded the stock to hold with a $9.00 target on May 20.

About Phreesia, Inc.

Phreesia, Inc., headquartered in Wilmington, Delaware, provides an integrated software and payment platform for the healthcare industry across the United States and Canada. Founded in 2005, the company offers a range of solutions including appointment and referral management, patient communications, and integrated payment solutions. Led by CEO Evan Roberts, Phreesia serves healthcare organizations such as ambulatory practices, health systems, and hospitals, as well as life sciences and government entities.

Bottom Line

Lainie Goldstein's purchase of Phreesia shares highlights insider confidence in the company's prospects. The stock, trading near $9.13, is watched by institutional investors and analysts alike. While insider transactions can offer insights, remember that they are historical and not necessarily indicative of future performance.